BiondVax is an Isreal-based biopharmaceutical company that develops and commercializes vaccines for the treatment of infectious and autoimmune diseases.
Business Model:
Revenue: $0
Employees: 11-50
Address: Hadassah Ein Kerem Campus
City: Jerusalem
State: center district
Zip: 9103401
Country: IL
BiondVax is an Isreal-based biopharmaceutical company that develops and commercializes vaccines for the treatment of infectious and autoimmune diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
5/11/2015
Ticker Symbol:
BVXV
IPO Price:
$5.01/share
Amount Raised:
$10M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2017 | Post-IPO Equity | $2.8M | 2/2021 | Post-IPO Equity | $12.1M | 12/2022 | Post-IPO Equity | $8M | 6/2017 | Post-IPO Debt | $26.9M |
European Investment Bank |
10/2018 | Post-IPO Debt | $9.2M |
European Investment Bank |
6/2017 | Post-IPO Debt | 1 | $22.3M |
European Investment Bank European Investment Bank European Investment Bank European Investment Bank |
12/2022 | Post-IPO Equity | $8M | 12/2021 | Post-IPO Equity | $9.8M | 9/2014 | Grant | 1 | $1.3M |
Office of the Chief Scientist Office of the Chief Scientist |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|